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Investigation on the treatment of subclinical endometritis with proteolytic enzymes or 
prostaglandin F2α in dairy cows 
 
Subclinical endometritis diagnosed by cytology in clinically healthy cows can be a reason for 
reduced reproductive performance. The objective of this study was to evaluate the effect of a 
treatment of subclinical endometritis with proteolytic enzymes or prostaglandin F2α compared 
to an untreated control group and a group of healthy cows without subclinical endometritis. 
       The field trial was conducted on a commercial dairy farm in Brandenburg, Germany. In 
all cows a first post partum check (PPC1) was performed between 21 and 27 days in milk. In 
cows without pathological findings (discharge or enlarged uterus) after rectal palpation and 
vaginoscopy endometrial cells were collected from the uterus using the cytobrush-method. An 
estimated percentage of ≥ 5% polymorphonuclear neutrophils (PMN) in the cytological 
sample was regarded as a sign for subclinical endometritis. Cows with subclinical 
endometritis were assigned to one of three treatment groups. In group “enzymes” cows 
received an intrauterine treatment with 20ml of a salve containing proteolytic enzymes   
(Masti Veyxym®, Veyx Pharma GmbH, Schwarzenborn, Germany). Masti Veyxym® contains 
chymotrypsin, trypsin, papain, vitamin A and vitamin E. In group “PGF” cows were treated 
with an injection of 0.5 mg of cloprostenol (PGF Veyx® forte, Veyx Pharma GmbH, 
Schwarzenborn, Germany). In group “control” cows with subclinical endometritis were not 
treated. In all animals a second post partum check (PPC2) was performed between 35 and 41 
days in milk using rectal palpation, vaginoscopy and the cytobrush-method. For the analysis 
of ovarian activity by progesterone a blood sample was taken at PPC1 and PPC2. A 
concentration above 1.0 ng/ml progesterone was considered indicative of an active corpus 
luteum. 
Of 315 clinically healthy cows at PPC1 50.2% had a subclinical endometritis. In primiparous 
cows subclinical endometritis was diagnosed significantly more often than in multiparous 
cows. Subclinical endometritis occured significantly more often in acyclic cows at PPC1 and 
PPC2 than in cows that already showed cyclic activity. Treatment of subclinical endometritis 
with proteolytic enzymes had positive influence on the clinical cure rate at PPC2 (58.8%) 
compared to the untreated control group (45.3%). The risk of an endometritis (clinical and 
subclinical) at PPC2 was significantly higher in group “PGF” (OR 2.1) and in the untreated 
control group (OR 3.0) compared to healthy cows at PPC1. 
Summary 
 84 
Regarding the reproductive performance there was no difference between healthy cows and 
cows with subclinical endometritis that were left untreated. This result is partly in 
contradiction to results of other studies. Therefore it would be of interest to determine the 
effect of subclinical endometritis detected at the time of insemination. 
First service conception rate, percentage of cows pregnant, days to first service and days open 
as well as other reproductive parameters did not differ significantly between the treatment 
groups and the healthy group. The treatment with proteolytic enzymes was beneficial only in 
multiparous cows. Compared to multiparous cows without subclinical endometritis the 
probability of pregnancy increased significantly (OR 4.7) and the probability of culling 
decreased significantly (OR 0.2). Compared to group “PGF” conception rate increased 
significantly as well (OR 3.0). Therefore further considerations about pathogenesis, therapy 
and impact of subclinical endometritis should include the age of the animals.
